PEN penumbrainc.com: Multiplikator Forward P/S
The implementation of ESG standards and the greening of production create a foundation for growth, as confirmed by the expected price-to-sales ratio, where the current figure stands at 5.30. Neurosurgeons' confidence in the unique tools of Penumbra, Inc. (PEN) and the full capacity utilization of modernized catheter manufacturing plants ensure sustainable development. This indicator's trend helps assess the business value relative to its ability to generate future revenues.
Rincian metrik lan analitis perusahaan Penumbra Medical (PEN)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Penumbra, Inc.|PEN - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Penumbra, Inc.|PEN - Utang perusahaan|Utang marang nilai buku Penumbra Medical|PEN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Penumbra|Likuiditas cepet penumbrainc.com
- rincian asil keuangan lan kelipatan valuasi:
PEN - Bathi resik taunan|Bathi mangsa ngarep Penumbra, Inc.|PEN - Pangali P/E|Pangali Forward P/E Penumbra Corp|PEN - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Penumbra Medical|PEN - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Penumbra|PEN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan penumbrainc.com|PEN - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Penumbra, Inc.
- indikator volume dodolan lan pendapatan:
Ringkesan analitik perusahaan:Penumbra (PEN)
The stability of Penumbra, Inc. (PEN) is underpinned by Adam Elsesser's reputation and the systemic implementation of innovations in thrombectomy. This indicator compares the current market value of the stock with expected sales volume, allowing for a real-time assessment of the value of each unit of future revenue. Investors should analyze the forward price-to-sales ratio trend to verify business expansion rates between quarterly reports.
Pesaing wigati
Multiplikator Forward P/S DXCM (Dexcom)|Novanta Inc (NOVT) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Haemonetics Corp. - Multiplikator Forward P/S|INSP (Inspire Medical Systems Inc) - Kapitalisasi marang prakiraan pendapatan|PRCT: Multiplikator Forward P/S|CNMD - Rasio kapitalisasi marang dodolan sing dikarepake|PLSE (Pulse Biosciences) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan InMode Ltd (INMD)|Multiplikator Forward P/S PMI|Multiplikator Forward P/S Surmodics Inc. (SRDX)|Rasio rega marang prakiraan pendapatan Senseonics Holdings SENS|neuropace.com - Rasio rega marang prakiraan pendapatan|TCMD: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SNWV (SANUWAVE Health)|OM: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Electromed (ELMD)|Rasio rega marang prakiraan pendapatan LENSAR, Inc.|RCEL - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan PROF (Profound Medical Corp.)|Multiplikator Forward P/S bairdmed.com (BDMD)|Multiplikator Forward P/S EDAP (EDAP TMS)|Rasio kapitalisasi marang dodolan sing dikarepake Apyx Medical Corp (APYX)|ICCM - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan CytoSorbents Corporation|SRTS (Sensus Healthcare Corp) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Zynex Corp ZYXI|Rasio rega marang prakiraan pendapatan electroCore, Inc. (ECOR)|vicarioussurgical.com - Kapitalisasi marang prakiraan pendapatan|Inspira Technologies - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICU (SeaStar Medical Holding Corporation)|IRIX - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan INBS|XAIR: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep profusa.com (PFSA)|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|Kapitalisasi marang prakiraan pendapatan GCTK (glucotrack.com)|Multiplikator forward rega marang pendapatan NAOV (NanoVibronix)|Multiplikator Forward P/S Venus Concept Corporation (VERO)|Rasio rega marang prakiraan pendapatan Nuwellis, Inc. NUWE|AEMD - Multiplikator forward rega marang pendapatan|TransEnterix - Multiplikator Forward P/S|AVGR: Rasio rega marang prakiraan pendapatan|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Cutera Inc - Rega forward marang dodolan|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S inarimedical.com|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
